Mirror life research trajectories: risks and considerations

What is the issue?

Abstract image of a DNA strand and branches, image by Alex/Adobe Stock

Photo by Alex/Adobe Stock

Many biological molecules come in two mirror-image forms, known as chiral molecules, similar to how left and right hands are reflections of each other. These mirror forms are chemically similar but not interchangeable. All known life relies exclusively on one set of these molecular “hands”.

Mirror life refers to hypothetical organisms made from the opposite set of these building blocks—mirror molecules. While individual mirror molecules may offer useful medical or research applications, a group of scientists has recently warned that mirror life could represent a risk to humans and the ecosphere. This is because the opposite chirality of mirror life might enable it to evade immune responses and detection systems tuned to natural life, raising serious concerns for biosecurity, health and environmental safety.

Despite these risks, there is no established mechanism for identifying which types of research should be restricted and what should be monitored, nor how to regulate research on mirror biomolecules without impeding legitimate scientific progress, particularly in the field of synthetic cells. Filling these knowledge gaps is essential for policymakers, funders, and security professionals working to strike a balance between fostering innovation and minimising harm.

How are we helping?

The RAND Europe and Meselson Center teams are working to understand developments that could facilitate the creation of mirror life, whether or not that was their intended effect. This project will make granular assessments of the technical steps to mirror life scientific milestones, economic and operational requirements, and the impact of progress in adjacent fields on mirror life development.

Our methodology combines targeted desk research, gap analysis and semi-structured interviews with leading domain experts to refine and validate technical assessments. A second track of work will draw on an expert tabletop scenario exercise and forecasting to model how scenarios may unfold over the next 10 years and the different types of regulations and oversight that could alter these roadmaps and scenarios. The project will regularly engage with policymakers, funders, and other global stakeholders, as well as collaborate with organisations such as the Mirror Biology Dialogues Fund to ensure complementarity and minimise information hazards.

We aim to produce a detailed, evidence-based assessment of research trajectories that could lead to the creation of mirror life and an analysis of how policy actions could mitigate risks while supporting innovations in synthetic biology that offer potential benefits.